Form 4 for AYTU AYTU BIOPHARMA, INC
Accepted 2022-11-21 00:00:00 ET · period of report 2022-11-18 · accession 0001654954-22-015599 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-11-21 | 2022-11-18 | AYTU | Disbrow Joshua R. | CEO, Dir | A - Grant | $0.24 | +222.0K | 1.12M | +25% | +$53.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2022-11-18 | A | A | 222,000 | $0.24 | 1,119,506 | D | — | — |